BROADCASTS.com

Every week, The American Journal of Managed Care\xae\xa0(AJMC\xae) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\n\nThis week, the top managed care news included CMS' proposal to cover\xa0chimeric antigen receptor T-cell therapy;\xa0a\xa0study faulting the FDA\u2019s handling of fentanyl oversight; and breast surgeons calling for genetic testing for all patients with breast cancer.\n\nRead more about the stories in this podcast:\nCMS Proposes That Patients Be Enrolled in Studies to Get Coverage for CAR T-Cell Therapy: https://www.ajmc.com/newsroom/cms-proposes-that-patients-be-enrolled-in-studies-to-get-coverage-for-car-tcell-therapy\nStudy Criticizes FDA Safety Oversight of Rapid-Release Fentanyl: https://www.ajmc.com/newsroom/study-criticizes-fda-safety-oversight-of-rapidrelease-fentanyl\nBreast Surgeons Seek Genetic Testing for All Patients With Breast Cancer: https://www.ajmc.com/newsroom/breast-surgeons-seek-genetic-testing-for-all-patients-with-breast-cancer\nGreater Diet Drink Consumption Heightens Stroke Risk in Postmenopausal Women: https://www.ajmc.com/newsroom/greater-diet-drink-consumption-heightens-stroke-risk-in-postmenopausal-women\nAdvancing Quality Oncology Care in the Evolving Value-Based Care Landscape: https://www.ajmc.com/ivbm-dallas